Amgen reports state of matter 2 Study Results for Brodalumab in Plaque disease of the skin RTT News (RTTNews) - Amgen (AMGN: News ) announced that results from a Phase 2 legal proceeding evaluating the safety and efficacy of brodalumab (formerly AMG 827) in 198 patients with moderate to severe plaque psoriasis were published in the brand-new England Journal of ... Link To Article
No comments:
Post a Comment